From: miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer
Age (years) Mean
65.4
Min - Max
50 - 79
PSA (ng/ml) Mean
11.0
2.0 – 37.0
<10 n (%)
27 (50.1)
≥10 n (%)
26 (49.9)
Stage
pT2 n (%)
22 (42.3)
pT3 n (%)
30 (57.7)
Gleason Score
< 7 n (%)
22 (41.5)
≥ 7 n (%)
31 (58.5)